PSYCHOLOGIX® has conducted more than 100 major multi-center clinical trials in support of:   New drug applications before the American Food and Drug Administration (FDA) or equivalent international regulatory bodies Substantiation of nutraceutical claims under the Dietary Supplement Health and Education Act (DSHEA) New or modified therapeutic claims for approved drugs or accepted nutraceuticals Safety and behavioral toxicity claims for drugs and nutraceuticals Applications for over-the-counter sale of prescribed drugs Pharmacoeconomic calculations Marketing efforts   These include trials designed to treat persons suffering from:   Age-Associated Memory Impairment (AAMI) Mild Cognitive Impairment (MCI) Alzheimer’s Disease (AD) Epilepsy Head Injury Stroke   As well as neurologically healthy person treated with:   Anti-hypertensive drugs Drugs that alter lipid metabolism Estrogen and selective estrogen release modulators Anti-histamine, anti-inflammatory, analgesic and other commonly used drugs   These latter studies were designed to establish the behavioral toxicity of drugs and procedures used to treat medical disorders and determine dosage levels, or variations on surgical procedures, that can be used safely.   We have also studied the effects of surgical procedures including:   Coronary Artery Bypass Graft Surgery Temporal Lobectomy